Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials.
Macchia A, Ferrante D, Bouzas MB, Angeleri P, Biscayart C, Geffner J, Mammana L, Zapiola I, López EL, Gentile A, Varese A, Mazzitelli I, García FDD, Sharff D, Lucconi V, Sujansky P, Mariani J, de Quirós FGB. Macchia A, et al. Lancet Reg Health Am. 2022 May;9:100196. doi: 10.1016/j.lana.2022.100196. Epub 2022 Feb 2. Lancet Reg Health Am. 2022. PMID: 35128512 Free PMC article.
The rationale and design of the FORomegaARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation.
Macchia A, Varini S, Grancelli H, Nul D, Laffaye N, Ferrante D, Tognoni G, Doval HC; FORomegaARD investigators. Macchia A, et al. Am Heart J. 2009 Mar;157(3):423-7. doi: 10.1016/j.ahj.2008.10.027. Epub 2009 Jan 8. Am Heart J. 2009. PMID: 19249410 Clinical Trial.
Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial.
Macchia A, Laffaye N, Comignani PD, Cornejo Pucci E, Igarzabal C, Scazziota AS, Herrera L, Mariani JA, Bragagnolo JC, Catalano H, Tognoni G, Nicolucci A. Macchia A, et al. PLoS One. 2012;7(3):e32894. doi: 10.1371/journal.pone.0032894. Epub 2012 Mar 28. PLoS One. 2012. PMID: 22470429 Free PMC article. Clinical Trial.
Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC; GESICA Investigators. Macchia A, et al. J Am Coll Cardiol. 2013 Jan 29;61(4):463-468. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19. J Am Coll Cardiol. 2013. PMID: 23265344 Free article. Clinical Trial.
Macitentan and pulmonary arterial hypertension.
Macchia A, Mariani J, Tognoni G. Macchia A, et al. N Engl J Med. 2014 Jan 2;370(1):82. doi: 10.1056/NEJMc1313112. N Engl J Med. 2014. PMID: 24382074 No abstract available.
129 results